PTSD

Brain Matters
Blog

Harnessing Memory’s Malleability to ‘Rewrite’ Fear and Other Negative Memories

Dr. Steve Ramirez is revealing where memories “live” in the brain, and explores how traumatic memories might be therapeutically modified.

Read More
2022 Leading Research Achievements
We are pleased to present you with the 2022 Leading Research Achievements by BBRF Grantees, Prizewinners & Scientific Council Members. Read More
A RESEARCHER'S PERSPECTIVE:  New Knowledge and New Treatment Possibilities in PTSD and Suicide

Lynnette Averill, Ph.D., a clinical psychologist affiliated with the Baylor College of Medicine, Yale University, and the Department of Veterans Affairs, studies the causes and consequences of trauma-related psychopathology and suicidality, and is investigating novel rapid-acting interventions. She explains her special interest in the role that ketamine and psychedelics (including psilocybin and MDMA) could play treating veterans and others with severe PTSD who are at high risk for suicidal thoughts and behaviors.

Read More
Accelerating Psychiatric Drug Development

Our PATHWAYS TO THE FUTURE story is about an unconventional approach to developing new psychiatric drugs. Based on an initiative by the National Institute of Mental Health, it’s called “Fast-Fail” and is designed to weed out the weakest drug candidates early in the process, to save time and money. In its first comprehensive test, a team led by two BBRF grantees and including 11 other BBRF grantees, Scientific Council members and prize winners, demonstrated the approach using a potential drug to treat anhedonia—the inability to experience or seek pleasure—which is seen in a number of psychiatric disorders including depression, anxiety, and PTSD.

Read More
RESILIENCE: A Q&A with Dr. Dennis S. Charney

A World Expert Discusses What Research and Personal Experience Have Taught Him

Read More